您的位置: 首页 > 农业专利 > 详情页

UTILISATION D'ANTAGONISTES DE NEUROKININE-1 DANS LE TRAITEMENT D'UNE VARIÉTÉ D'ÉTATS PRURITIQUES
专利权人:
Menlo Therapeutics Inc.
发明人:
BASTA, Steven,JOING, Mark,ZHANG, Xiaoming,KWON, Paul
申请号:
EP17821188
公开号:
EP3478283A4
申请日:
2017.06.28
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The disclosure relates to the use of neurokinin-1 (NK-1) antagonists, such as serlopitant, in treating acute or chronic pruritus associated with a variety of medical conditions, including dermatitis/eczema, psoriasis, prurigo, urticaria, cutaneous T-cell lymphoma, epidermolysis bullosa, bums and hepato-biliary diseases, or/and treating the medical conditions themselves. One or more additional antipruritic or therapeutic agents can optionally be used in combination with an NK-1 antagonist to treat acute or chronic pruritus associated with a medical condition or/and the medical condition itself.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充